» Articles » PMID: 1950962

Drug-nutrient Interactions

Overview
Specialty Public Health
Date 1991 Nov 1
PMID 1950962
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Drug-nutrient interactions are a commonly overlooked aspect of the prescribing practices of physicians. As more pharmaceutical agents become available, attention should be focused on interactions of drugs with foods and nutrients. Although drug-nutrient interactions are not as common as drug-drug interactions, they can have an impact on therapeutic outcome. Drugs can affect nutritional status by altering nutrient absorption, metabolism, utilization or excretion. Food, beverages and mineral or vitamin supplements can affect the absorption and effectiveness of drugs. Knowledge of drug-nutrient interactions can help reduce the incidence of these effects. Physicians should question patients about their dietary habits so that patients can be informed about possible interactions between a prescribed drug and foods and nutrients.

Citing Articles

Carbon Disulfide (CS2) Interference in Glucose Metabolism from Unconventional Oil and Gas Extraction and Processing Emissions.

Rich A, Patel J, Al-Angari S Environ Health Insights. 2016; 10:51-7.

PMID: 27042092 PMC: 4811267. DOI: 10.4137/EHI.S31906.


The role of nutrition and nutraceutical supplements in the treatment of hypertension.

Houston M World J Cardiol. 2014; 6(2):38-66.

PMID: 24575172 PMC: 3935060. DOI: 10.4330/wjc.v6.i2.38.


Body composition of rheumatoid arthritis patients in the City of Cape Town, South Africa.

Lombard L, Du Plessis L, Visser J Clin Rheumatol. 2013; 33(4):467-76.

PMID: 24196988 DOI: 10.1007/s10067-013-2414-0.


Nutrition and nutraceutical supplements for the treatment of hypertension: part III.

Houston M J Clin Hypertens (Greenwich). 2013; 15(12):931-7.

PMID: 24119210 PMC: 8033946. DOI: 10.1111/jch.12211.


Impact of voglibose on the pharmacokinetics of dapagliflozin in Japanese patients with type 2 diabetes.

Imamura A, Kusunoki M, Ueda S, Hayashi N, Imai Y Diabetes Ther. 2013; 4(1):41-9.

PMID: 23307267 PMC: 3687097. DOI: 10.1007/s13300-012-0016-5.